Soluble plasma HLA peptidome as a potential source for cancer biomarkers
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The HLA molecules are membrane-bound transporters that carry peptides from the cytoplasm to the cell surface for surveillance by circulating T lymphocytes. Although low levels of soluble HLA molecules (sHLA) are normally released into the blood, many types of tumor cells release larger amounts of these sHLA molecules, presumably to counter immune surveillance by T cells. Here we demonstrate that these sHLA molecules are still bound with their authentic peptide repertoires, similar to those of the membranal HLA molecules (mHLA). Therefore, a single immunoaffinity purification of the plasma sHLA molecules, starting with a few milliliters of patients’ blood, allows for identification of very large sHLA peptidomes by mass spectrometry, forming a foundation for development of a simple and universal blood-based cancer diagnosis. The new methodology was validated using plasma and tumor cells of multiple-myeloma and leukemia patients, plasma of healthy controls, and with cultured cancer cells. The analyses identified thousands of sHLA peptides, including some cancer-related peptides, present among the sHLA peptidomes of the cancer patients. Furthermore, because the HLA peptides are the degradation products of the cellular proteins, this sHLA peptidomics approach opens the way for investigation of the patterns of protein synthesis and degradation within the tumor cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This approach can yield substantial quantities of HLA-peptide complexes that can be easily purified from the medium before nUPLC-MS/MS analysis.”
From Mass spectrometry–based identification of MHC-bound peptides for immunopeptidomics (2019) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eng, J. K., McCormack, A. L., & Yates, J. R. (1994) · Journal of the American Society for Mass Spectrometry · doi:10.1016/1044-0305(94)80016-2 · Cited by 6,484 · cited 1×
“0 SP1 (Thermo) combining the search results of Seques t (Thermo-Fisher) (40) and Mascot (server 2.”
HLA class I supertypes: a revised and updated classification
Sidney, J., Peters, B., Frahm, N., Brander, C., & Sette, A. (2008) · BMC Immunology · doi:10.1186/1471-2172-9-1 · Cited by 775
Yewdell, J. W., Antón, L. C., & Bennink, J. R. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.5.1823 · Cited by 450
The Turnover Kinetics of Major Histocompatibility Complex Peptides of Human Cancer Cells
Milner, E., Barnea, E., Beer, I., & Admon, A. (2006) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500241-mcp200 · Cited by 122 · cited 1×
“These proteins are often too short lived to be detected in the cancer tissues by regular proteomics methodologies, but may become detectable through their proteolysis products, namely the HLA peptides (30).”
Self-citation
Research works printed but not linked: 40
- 10.1172/JCI27467 · DOI · Paper page
- 10.1373/clinchem.2005.053090 · DOI · Paper page
- 10.1373/clinchem.2005.052944 · DOI · Paper page
- 10.1074/mcp.M600229-MCP200 · DOI · Paper page
- 10.1172/JCI26022 · DOI · Paper page
- 10.1016/j.immuni.2006.10.008 · doi:10.1016/j.immuni.2006.10.008
- 10.1038/nrd2224 · DOI · Paper page
- 10.1074/mcp.R300004-MCP200 · DOI
- 10.1038/sj.leu.2404506 · doi:10.1038/sj.leu.2404506
- 10.1016/j.leukres.2006.02.013 · DOI
- 10.1158/1078-0432.CCR-05-0456 · DOI
- 10.1016/S0198-8859(97)00227-9 · doi:10.1016/s0198-8859(97)00227-9
- 10.1016/S0198-8859(01)00246-4 · DOI
- 10.1002/art.1780390511 · doi:10.1002/art.1780390511
- 10.1016/S1081-1206(10)63096-7 · DOI
- 10.1136/ard.59.1.20 · doi:10.1136/ard.59.1.20
- 10.1016/j.humimm.2008.01.006 · doi:10.1016/j.humimm.2008.01.006
- 10.1016/S0198-8859(00)00213-5 · DOI
- 10.1016/S0021-9258(17)37430-6 · DOI
- 10.1084/jem.163.5.1173 · DOI · Paper page
- 10.1016/j.leukres.2006.06.008 · DOI
- 10.1111/j.1399-0039.2008.01106.x · DOI
- 10.1016/j.jhep.2005.05.026 · DOI · Paper page
- 10.1093/intimm/12.2.195 · DOI
- 10.1182/blood.V99.5.1706 · DOI
- 10.1038/nm0996-1005 · DOI · Paper page
- 10.1080/08820130600808246 · DOI
- 10.1007/s00262-004-0560-6 · DOI · Paper page
- 10.4049/jimmunol.178.4.1975 · DOI
- 10.1038/leu.2008.340 · DOI
- 10.1182/blood.V96.2.655.014k10_655_663 · doi:10.1182/blood.v96.2.655.014k10_655_663
- 10.1038/leu.2009.33 · DOI · Paper page
- 10.1038/nbt1070 · DOI · Paper page
- 10.4049/jimmunol.170.8.4349 · DOI
- 10.1016/S0021-9673(02)01402-4 · DOI · Paper page
- 10.1002/pmic.200300652 · DOI · Paper page
- 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2 · DOI · Paper page
- KC Parker, MA Bednarek, JE Coligan, Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 152, 163–175 (1994). · DOI · Paper page
- 10.1002/jms.465 · doi:10.1002/jms.465
- 10.1007/s002510050595 · DOI · Paper page
Cited by
Radiotherapy combination opportunities leveraging immunity for the next oncology practice
Herrera, F. G., Bourhis, J., & Coukos, G. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21358 · Cited by 509
Bassani-Sternberg, M., Pletscher-Frankild, S., Jensen, L. J., & Mann, M. (2015) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m114.042812 · Cited by 426
Self-citationMass spectrometry–based identification of MHC-bound peptides for immunopeptidomics
Purcell, A. W., Ramarathinam, S. H., & Ternette, N. (2019) · Nature Protocols · doi:10.1038/s41596-019-0133-y · Cited by 394
UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma
Wolf, Y., Bartok, O., Patkar, S., Eli, G. B., Cohen, S., Litchfield, K., Levy, R., Jiménez-Sánchez, A., Trabish, S., Lee, J. S., et al. (2019) · Cell · doi:10.1016/j.cell.2019.08.032 · Cited by 380
Self-citationWhole Tumor Antigen Vaccines: Where Are We?
Chiang, C., Coukos, G., & Kandalaft, L. (2015) · Vaccines · doi:10.3390/vaccines3020344 · Cited by 269
Metadata
- Authors
- Bassani-Sternberg, M., Barnea, E., Beer, I., Avivi, I., Katz, T., & Admon, A.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2010-10-25
- Volume
- 107
- Issue
- 44
- Pages
- 18769-18776
- ISSN
- 0027-8424
- 1091-6490
- Cited by
- 121
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.